Science

In the latest round of AI funding, Israeli startup, Nucleai raised $5 million in seed round led by Vertex Ventures Israel and Grove Ventures Capital (GP) Ltd. Nucleai, a Tel Aviv-based startup, is developing an AI pathology system to help...

A pair of recently developed AI systems can diagnose lung cancer and heart disease more accurately than human doctors. These AIs have the potential to save billions of dollars and countless lives if widely adopted. Improved...

Irène Villa PhD, Marie-Christine Mathieu MD, Jacques Bosq MD, Anne Auperin PhD, Jean-François Pomerol PhD, Magali Lacroix-Triki MD PhD, Jean-Yves Scoazec MD PhD, Peggy Dartigues MD American Journal of Clinical Pathology,...

25 million slides in an exclusive relationship with MSK and 25 million dollars in funding are some big numbers.  Paige.AI, a new company focused on revolutionizing clinical diagnosis and treatment in oncology through use of artificial...

February 12-14, 2018   |   Moscone South Convention Center   |   San Francisco, CA Triconference.com/Digital-Pathology Bristol-Myers Squibb and Genentech to Present on Benefits of Multiplex Immunohistochemistry at CHI's Digital...

Multi-disciplinary tumor boards (MDT) have been the highlight of cancer programs for years and enable the delivery of well-coordinated care and bring the expertise of numerous specialties to each patient case. Previous studies have shown that...